South Korea’s GC Biopharma Corp. has gained U.S. FDA approval for its immune-deficiency plasma drug, Alyglo (immune globulin intravenous, human-stwk; IVIG-SN 10%), five months after refiling its BLA, five months after refiling its BLA and before its PDUFA date of Jan. 13, 2024.
Global Biobetters Market is projected to reach US$ 99 2 Bn by the year 2029 at a 8 3% CAGR | Lower Dosage Frequency to drive market expansion | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Antithrombin is a protein present in blood that inhibits blood clotting by inactivating thrombin, which is produced by liver and consists of 432 amino acids.
/PRNewswire/ The "Influenza Vaccines: Global Markets" report has been added to ResearchAndMarkets.com s offering. The report explains critical trends in the.